[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
October 1982

To the Editor.-Reply

Author Affiliations


Arch Intern Med. 1982;142(10):1971. doi:10.1001/archinte.1982.00340230221042

—We appreciate the comments by Dr Feagin and Mr Dorr who both suggest alternative mechanisms for the severe neutropenia seen in patients treated with carmustine and cimetidine. Inhibition of the cytochrome system or alteration of hepatic blood flow by cimetidine may potentially delay the clearance of chemotherapeutic agents. This could increase their toxic or therapeutic effects.1

In our practice, we have seen one patient with a reversible neutropenia and another with severe aplastic anemia that followed ingestion of cimetidine. Since these patients were not receiving cytotoxic drugs, it seems likely that cimetidine can act to suppress marrow function. Further investigation should help to resolve the question of direct v indirect effect on the hematopoietic stem cell.